How Spain Attracted Investment From Pharma Giants AstraZeneca, Novartis, Roche - Bloomberg


Big Pharma has aimed some choice words at European countries in recent weeks, including calling the UK “uninvestable” and warning that the region as a whole is fast losing its edge to China.

Yet even as Europe is buffeted by change — the clamor for Chinese biotech or, more recently, the rush to appease US President Donald Trump — one country is showing there could still be a way to build up a pharmaceutical industry: by giving companies what they want.

Was this article displayed correctly? Not happy with what you see?

We located an Open Access version of this article, legally shared by the author or publisher. Open It

Share this article with your
friends and colleagues.
Earn points from views and
referrals who sign up.
Learn more

Facebook

Save articles to reading lists
and access them on any device


Share this article with your
friends and colleagues.
Earn points from views and
referrals who sign up.
Learn more

Facebook

Save articles to reading lists
and access them on any device